Centrex, Inc. Names Jeffrey Flannery Chief Business Development Officer
10/19/2005 5:09:18 PM
Centrex, Inc. (OTCBB:CNEX) today announced that Jeffrey Flannery has been named as the Company's Chief Business Development Officer. Mr Flannery will assume and expand upon some of the duties currently undertaken by Centrex CEO Dr. Thomas R. Coughlin, Jr. Dr. Coughlin will continue as CEO and Chief Science Officer and will concentrate his efforts on supervising the commercialization of the Centrex Single Molecule Nucleic Acid Detection (SMD) technology.
comments powered by